All news from Anaesthesiology

Stannsoporfin: FDA Panel Urges Rejection

Federal advisers dealt a setback to the developers of the experimental medicine stannsoporfin for newborns who cannot quickly clear bilirubin and thus risk developing jaundice, by a 21-3 vote recommending rejection of manufacturer Mallinckrodt's application for approval of the drug.

VR-based Treatment for Spatial Deficit after Stroke

Kessler Foundation, a leader in rehabilitation research, has partnered with Virtualware Group, an international leader in immersive and interactive technologies, to create a virtual reality (VR) based treatment for spatial neglect, the most common spatial deficit after stroke.

The treatment called VR-SRT System, which will be under direction of Peii Chen, is an intervention that enhances therapy participation through a safe, interactive, and game-like VR environment. The flexibility of the VR-SRT System allows the tool to be implemented in various clinical settings and the home.

Insights on COPD-associated Inflammation

Chronic obstructive pulmonary disease (COPD)is believed to be the third most common cause of death worldwide. However, because the underlying mechanism is still largely unknown, today's treatments can only slow progression of the disease.

Scientists have now reported a previously unknown pathogenic mechanism, which they have already been able to prevent in the laboratory. Their findings are reported in EMBO Molecular Medicine.

hiPSC-Based Therapy for Hereditary Diseases

Researchers at Li Ka Shing Faculty of Medicine of The University of Hong Kong (HKU) have successfully demonstrated the use of human induced pluripotent stem cells (hiPSCs) from patients' skin cells for therapeutic drug testing.

The success of the research implies that scientists are one step closer to applying stem cells in precision medicine in treating patients suffering from rare hereditary diseases.